Inventor · disambiguated record
Michael G. Palfreyman
Also filed as: PALFREYMAN MICHAEL · PALFREYMAN MICHAEL G
31 granted patents·17 pending applications·1,275 citations·filing 1981–2025
97Inventor score
Files withCYBIN IRL LTD21MERRELL DOW PHARMA20MERRELL TORAUDE & CO3PSYCHIATRIC GENOMICS INC3MERRELL PHARMA INC1
Top patents by PatentIndex Score
48 records- 0198US11242318B2Deuterated tryptamine derivatives and methods of useCYBIN IRL LTD·Filed 2021·Granted Feb 8, 2022·38 cites·53 claims
- 0297US11724985B2Deuterated tryptamine derivatives and methods of useCYBIN IRL LTD·Filed 2021·Granted Aug 15, 2023·7 cites·12 claims
- 0396US11834410B2Deuterated tryptamine derivatives and methods of useCYBIN IRL LTD·Filed 2023·Granted Dec 5, 2023·5 cites·10 claims
- 0496US11746088B2Deuterated tryptamine derivatives and methods of useCYBIN IRL LTD·Filed 2022·Granted Sep 5, 2023·5 cites·11 claims
- 0595US5252608AInhibitors of lysyl oxidaseMERRELL DOW PHARMA·Filed 1992·Granted Oct 12, 1993·178 cites·8 claims
- 0695US5021456AInhibitors of lysyl oxidaseMERRELL DOW PHARMA·Filed 1990·Granted Jun 4, 1991·185 cites·7 claims
- 0795US4965288AInhibitors of lysyl oxidaseMERRELL DOW PHARMA·Filed 1989·Granted Oct 23, 1990·180 cites·7 claims
- 0894US5182297AInhibitors of lysyl oxidaseMERRELL DOW PHARMA·Filed 1991·Granted Jan 26, 1993·169 cites·5 claims
- 0994US4943593AInhibitors of lysyl oxidaseMERRELL DOW PHARMA·Filed 1989·Granted Jul 24, 1990·169 cites·7 claims
- 1093US5059714AInhibitors of lysyl oxidaseMERRELL DOW PHARMA·Filed 1991·Granted Oct 22, 1991·155 cites·5 claims
- 1193US5011846AMedicament compositions derived from quinolizine and quinolizinone and methods of use thereofMERRELL DOW PHARMA·Filed 1990·Granted Apr 30, 1991·67 cites·15 claims
- 1291US2025011282A1Deuterated tryptamine derivatives and methods of useCYBIN IRL LTD·Filed 2024·Application pending·0 cites
- 1390US4421767ACompounds and methods for treating depressionMERRELL TORAUDE & CO·Filed 1982·Granted Dec 20, 1983·21 cites·36 claims
- 1485US12110272B2Deuterated tryptamine derivatives and methods of useCYBIN IRL LTD·Filed 2023·Granted Oct 8, 2024·0 cites·18 claims
- 1583US4650907ANonaromatic fluoroallylamine MAO inhibitorsMERRELL DOW PHARMA·Filed 1985·Granted Mar 17, 1987·18 cites·16 claims
- 1682US2023126298A1Deuyerated tryptamine derivative formulations and methods of useCYBIN IRL LTD·Filed 2022·Application pending·0 cites
- 1781US4346110AMethod for treating depressionMERRELL TORAUDE & CO·Filed 1981·Granted Aug 24, 1982·12 cites·3 claims
- 1879US12240813B2Deuterated tryptamine derivatives and methods of useCYBIN IRL LTD·Filed 2021·Granted Mar 4, 2025·0 cites·20 claims
- 1979US5547991ANMDA antagonism methodMERRELL PHARMA INC·Filed 1995·Granted Aug 20, 1996·19 cites·10 claims
- 2077US2025154101A1Deuterated tryptamine derivatives and methods of useCYBIN IRL LTD·Filed 2025·Application pending·0 cites
- 2168US4413012AMethod for treating depressionMERRELL TORAUDE & CO·Filed 1982·Granted Nov 1, 1983·6 cites·9 claims
- 2266US2024425451A1Therapeutic phenethylamine compositions and methods of useCYBIN IRL LTD·Filed 2024·Application pending·0 cites
- 2365US2025082607A2Methods of treating disorders with a psilocybin analogCYBIN IRL LTD·Filed 2024·Application pending·0 cites
- 2462US2025360148A1Solid dispersions of psilocybinCYBIN IRL LTD·Filed 2023·Application pending·0 cites
- 2561US12122741B2Therapeutic phenethylamine compositions and methods of useCYBIN IRL LTD·Filed 2021·Granted Oct 22, 2024·0 cites·13 claims
- 2660US5470870ANMDA antagonistsMERRELL DOW PHARMA·Filed 1994·Granted Nov 28, 1995·5 cites·9 claims
- 2760US2025213527A1Formulations of psilocybin analogs and methods of useCYBIN IRL LTD·Filed 2022·Application pending·0 cites
- 2859US2024174607A1Psilocybin analogs, salts, compositions, and methods of useCYBIN IRL LTD·Filed 2022·Application pending·0 cites
- 2958US2024261306A1Formulations of psilocybinCYBIN IRL LTD·Filed 2022·Application pending·0 cites
- 3058US2025205198A1Methods for delivery of psychedelic medications by inhalation and systems for performing the methodsCYBIN IRL LTD·Filed 2023·Application pending·0 cites
- 3156US4916151AMethod of treating parkinson's syndromeMERRELL DOW PHARMA·Filed 1989·Granted Apr 10, 1990·19 cites·9 claims
- 3255US2025236589A1Therapeutic phenethylamine compositions and methods of useCYBIN IRL LTD·Filed 2023·Application pending·0 cites
- 3353US2025145566A1Phenethylamine derivatives, compositions, and methods of useCYBIN IRL LTD·Filed 2023·Application pending·0 cites
- 3452US2024366655A1Combination drug therapiesCYBIN IRL LTD·Filed 2022·Application pending·0 cites
- 3552US2023355583A1Methods for delivery of psychedelic medications by inhalation and systems for performing the methodsCYBIN IRL LTD·Filed 2021·Application pending·0 cites
- 3648US5082837ALactamimides as calcium antagonistsMERRELL DOW PHARMA·Filed 1990·Granted Jan 21, 1992·12 cites·9 claims
- 3742US2005181433A1Multi-parameter high throughput screening assays (MPHTS)PSYCHIATRIC GENOMICS INC·Filed 2005·Application pending·0 cites
- 3840US5360814ANMDA antagonistsMERRELL DOW PHARMA·Filed 1994·Granted Nov 1, 1994·1 cites·6 claims
- 3939US2003096264A1Multi-parameter high throughput screening assays (MPHTS)PSYCHIATRIC GENOMICS INC·Filed 2002·Application pending·0 cites
- 4038US2007142399A1Dual function drugs and uses thereofPSYCHIATRIC GENOMICS INC·Filed 2004·Application pending·0 cites
- 4136US5484814ANMDA antagonistsMERRELL DOW PHARMA·Filed 1993·Granted Jan 16, 1996·0 cites·11 claims
- 4236US4822812Aβ-(Fluoromethylene)-5-hydroxytryptophan and derivatives and their use as prodrugs for MAO inhibitionMERRELL DOW PHARMA·Filed 1987·Granted Apr 18, 1989·1 cites·14 claims
- 4334US5198433ALactamimides as calcium antagonistsMERRELL DOW PHARMA·Filed 1992·Granted Mar 30, 1993·3 cites·6 claims
- 4433US4879305AUse of β-(fluoromethylene)-5-hydroxytryptophan and derivatives as prodrugs and mao inhibitionMERRELL DOW PHARMA·Filed 1988·Granted Nov 7, 1989·0 cites·13 claims
- 4531US5010072ALactamimides as calcium antagonistsMERRELL DOW PHARMA·Filed 1988·Granted Apr 23, 1991·0 cites·5 claims
- 4630US5158945ALactamimides as calcium antagonistsMERRELL DOW PHARMA·Filed 1992·Granted Oct 27, 1992·0 cites·4 claims
- 4730US5128337ALactamimides as calcium antagonistsMERRELL DOW PHARMA·Filed 1991·Granted Jul 7, 1992·0 cites·8 claims
- 4823US4916140AAntiepileptic pyrazolopyridinesMERRELL DOW PHARMA·Filed 1988·Granted Apr 10, 1990·0 cites·5 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →